These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 25702912
41. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T. Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574 [Abstract] [Full Text] [Related]
42. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films. Paudel A, Nies E, Van den Mooter G. Mol Pharm; 2012 Nov 05; 9(11):3301-17. PubMed ID: 23009610 [Abstract] [Full Text] [Related]
43. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release. Meeus J, Lenaerts M, Scurr DJ, Amssoms K, Davies MC, Roberts CJ, Van Den Mooter G. J Pharm Sci; 2015 Apr 05; 104(4):1451-60. PubMed ID: 25648704 [Abstract] [Full Text] [Related]
44. The influence of drug and polymer particle size on the in situ amorphization using microwave irradiation. Hempel NJ, Knopp MM, Berthelsen R, Zeitler JA, Löbmann K. Eur J Pharm Biopharm; 2020 Apr 05; 149():77-84. PubMed ID: 32035238 [Abstract] [Full Text] [Related]
45. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Ghebremeskel AN, Vemavarapu C, Lodaya M. Int J Pharm; 2007 Jan 10; 328(2):119-29. PubMed ID: 16968659 [Abstract] [Full Text] [Related]
46. Amorphous Fluoropolymer Membrane for Gas Separation Applications. Son TY, Jeong MA, Nam SY. J Nanosci Nanotechnol; 2018 Sep 01; 18(9):6206-6212. PubMed ID: 29677768 [Abstract] [Full Text] [Related]
47. Measurement of low amounts of amorphous content in hydrophobic active pharmaceutical ingredients with dynamic organic vapor sorption. Müller T, Schiewe J, Smal R, Weiler C, Wolkenhauer M, Steckel H. Eur J Pharm Biopharm; 2015 May 01; 92():102-11. PubMed ID: 25779351 [Abstract] [Full Text] [Related]
48. Determination of the glass transition temperatures of some new methyl methacrylate copolymers using modulated temperature differential scanning calorimetry (MTDSC). Ferrero MC, Velasco MV, Ford JL, Rajabi-Siahboomi AR, Muñoz A, Jiménez-Castellanos MR. Pharm Res; 1999 Sep 01; 16(9):1464-9. PubMed ID: 10496666 [Abstract] [Full Text] [Related]
51. Stabilisation of amorphous drugs under high humidity using pharmaceutical thin films. Ng YC, Yang Z, McAuley WJ, Qi S. Eur J Pharm Biopharm; 2013 Aug 01; 84(3):555-65. PubMed ID: 23403014 [Abstract] [Full Text] [Related]
52. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. Mol Pharm; 2005 Aug 01; 2(5):384-91. PubMed ID: 16196491 [Abstract] [Full Text] [Related]
53. Characterization of the film formation of the dry coating process. Kablitz CD, Urbanetz NA. Eur J Pharm Biopharm; 2007 Sep 01; 67(2):449-57. PubMed ID: 17451928 [Abstract] [Full Text] [Related]